In addition, anti-AT1R and anti-ETAR are considered the main non-HLA antibodies involved in allograft transplant rejection, which is an intriguing point considering that graft versus host disease (GVHD) shares several similarities with scleroderma [17]. This evidence concerns the gene AGTR1 and graft versus host disease.